We live in the rebirth era of psychotherapy. Although entheogens or “psychedelics” are criminalized and criminalized worldwide, countries that invented a ban on them like the United States have recently seen a rebirth in their medical use and research.
There are more than 150 species of psylocibin fungi worldwide. Numerous records indicate that the different founding Empires of Mesoamerica and different parts of the world resorted to such treatments being considered medical, spiritual, shamanistic or religious tools.
Western medicine has been interested in this kind of world view for some time. However, his research has been hampered by the Drug Control Administration (DEA) and its institutions operating in different countries.
Still, research in these countries has been corroborated with the founding sites of medicine. Concluding that it can be a treatment for anxiety, depression, post-traumatic stress syndrome (PTSD) since its properties are able to generate extreme happiness.
Sense of spiritual well-being
A study published in Psychopharmacology published in 2006 found that patients who consumed this substance showed an increase in “their positive attitudes, moods, social and behavioral effects”, after two months. In addition, research conducted by Roland R. Griffiths reports that people reported a deep level of positivism, a state of consciousness and sacrality with life.
Depression
The Imperial School of London found great benefits in using psilocybin to treat feelings of depression and desolation. The clinical trial showed that two doses of the substance were sufficient to suspend severe depressions in volunteers. Five of these volunteers remained without these episodes for three months, while the remaining ones for three weeks.
Anxiety
A 2016 study concluded that a simple dose of psilocybin administered to 29 people with terminal cancer was enough to bring a mental well-being. Each was also diagnosed with anxiety or depression because of his illness. After six months of taking this medicine between 60 and 80 percent of patients reported a significant reduction in both symptoms.
In conclusion, just as it has been with cannabis, such discoveries canhelppeople access naturalconditions legally. Recently, Oregon and Canada became the first place to regulate medical access to this medicine.